Skip to content

VALN

Valneva SE

NASDAQ · Healthcare · Biotechnology · FR

$5.51
−1.78%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
8.50x
P/E 2028E
15.92x
P/S forward
2.65x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
5.74x
Price / sales
3.25x
Price / cash flow
-5.60x

Enterprise value

Enterprise value
$621.9M
EV / sales
3.86x
EV / EBITDA
-5.95x
EV / EBIT
-4.77x
Market cap
$522.5M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026